YZN-21709-44515
4 vaccinations
5 coded responses
43 check-ins
4 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 605 / IL
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XKR-11485-02356
Child or adolescent in my care · Female · 2022-07-13
X8R-26974-03598
Child or adolescent in my care · Male · 2022-07-13
Timeline
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Registered in v-safe
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Fever · Chills, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-13
- 2021-05-18
- 2021-07-06
-
2021-10-05
Dose 3 — Pfizer-BioNTech
- 2021-10-05
-
2021-10-05
Survey response — day 0, dose 3MedDRA: Dizziness — Feeling: Fair · HeadacheFree text: Light headedMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-10
- 2021-10-11
- 2021-10-14
- 2021-10-19
- 2021-10-28
- 2021-11-02
- 2021-11-10
- 2021-11-16
-
2022-01-04
Survey response — 3 months, dose 3MedDRA: Amniotic fluid volume decreased, Chills, Influenza virus test negative, Pyrexia, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever and chills for < day; covid and flu negative Low amniotic fluidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-04
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-06
-
2022-04-05
Survey response — 6 months, dose 3MedDRA: Anaemia, Caesarean section, Delivery, Wound infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Had baby 1/25/22. Still have anemia and csection wound infection twiceMedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-12
-
2022-10-05
Survey response — 12 months, dose 3MedDRA: COVID-19, Malaise, Nasopharyngitis — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I've had Covid and two colds. Currently sick with cold number 2MedDRA releases: 2024-11 · check-in free text available
-
2022-10-05
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-06
- 2022-10-06
- 2022-10-06
-
2023-01-31
Dose 4 — Moderna
- 2023-01-31
-
2023-02-01
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2023-02-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2023-02-03
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2023-02-04
- 2023-02-05
- 2023-02-06
- 2023-02-15
- 2023-02-23
- 2023-03-02
-
2023-03-07
Survey response — day 35, dose 4MedDRA: Diarrhoea, Dizziness, Fatigue, Headache, Pyrexia, Vomiting, Weight decreased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-03-07
Report sent to call center — day 35, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-03-08
- 2023-03-08
- 2023-03-08
- 2023-03-08
- 2023-03-14
- 2023-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2023-01-31 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-04 | Unsuccessful | |
| 2022-04-05 | Unsuccessful | |
| 2022-10-05 | Unsuccessful | |
| 2023-03-07 | Unsuccessful |
Free text
Release 10 — day 0, dose 3
Systemic reaction (other): Light headed
Release 10 — 3 months, dose 3
Symptoms: Fever and chills for < day; covid and flu negative Low amniotic fluid
Release 11 — 6 months, dose 3
Symptoms: Had baby 1/25/22. Still have anemia and csection wound infection twice
Release 12 — 12 months, dose 3
Symptoms: I've had Covid and two colds. Currently sick with cold number 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Amniotic fluid volume decreased | · | · | ✓ |
| SD | Anaemia | · | · | ✓ |
| SD | Caesarean section | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Influenza virus test negative | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SD | Weight decreased | · | · | ✓ |
| SD | Wound infection | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release